+1 (502) 904-2126   One Westbrook Corporate Center, Suite 300, Westchester, IL 60154, USA   Site Map
ISSN: 2574 -1241

Impact Factor : 0.548

  Submit Manuscript

Research ArticleOpen Access

Low-Molecular Weight Heparin/Protamine Micro-Nanoparticles Augmented Viability of Human Adipose-Derived Regenerative Cells

Volume 12 - Issue 3

Masashi Sakuma1,3, Satoko Kishimoto*2,3, Ken-ichi Inoue2,3, Ryoichi Sohma2, Shigeru Toyoda1,3, Hideki Iwaguro1,3 and Teruo Inoue*1,2,3

  • Author Information Open or Close
    • 1Department of Cardiovascular Medicine, Japan
    • 2Research Support Center, Japan
    • 3Center for Regenerative Medicine, Japan
    • *Corresponding author: Teruo Inoue, Department of Cardiovascular Medicine, Japan and Satoko Kishimoto, Research Support Center, Center for Regenerative Medicine Tochigi, Japanb

Received: December 12, 2018;   Published: December 21, 2018

DOI: 10.26717/BJSTR.2018.12.002509

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF


Background: Low molecular weight heparin/protamine micro/nanoparticles (LH/P-MPs) has been shown as cell carriers for adipose-derived regenerative cells (ADRCs) to augment cell viability, leading to accelerating angiogenesis in mouse limb ischemia models, compared to ADRCs alone.

Material & Methods: Human ADRCs were isolated from 3 patients with critical limb ischemia and incubated with and without LH/P-MPs Incubation of ADRCs with LH/P-MPs produced cell aggregation (ADRC/LH/P-MPs aggregates). Serial changes in survived ADRCs were compared between ADRC/LH/P-MPs aggregates and ADRCs alone.

Results: Patients’ derived ADRCs promptly decreased cell number in suspension culture, eventually they were eliminated through cell death after seven days. ADRC/LH/P-MPs aggregates remarkably slowed down the cell death.

Conclusion: The LH/P-MPs could enhance the viability of human ADRCs. The LH/P-MPs could be a promising option in ADRCs-based therapeutic angiogenesis in patients with critical limb ischemia.

Keywords :Limb Ischemia; Adipose-Derived Regenerative Cells; Low Molecular Weight Heparin/Protamine Micro/Nanoparticles; Angiogenesis Therapy; Human

Introduction| Materials and Methods| Results| Discussion| References|